Press Release Press Release Cardiac Dimensions Announces $17.5 Million Series C Financing to Accelerate Sales Expansion of the Carillon Mitral Contour System® Funds to be Used for Commercial Expansion in Europe and Australia KIRKLAND, WA – September 29, 2020 — Cardiac...
Press Release Press Release Cardiac Dimensions Announces Australian Therapeutic Goods Administration’s Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation KIRKLAND, WA – September 2, 2020 — Cardiac Dimensions®, a leader in the...
Press Release Press Release Cardiac Dimensions hires Gretchen Gary as Vice President of Global Therapy Development KIRKLAND, WA – March 5, 2020 — Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral...
Press Release Press Release New Data Confirms Cardiac Dimensions’ Carillon System Shows Favorable Long-Term Survival Rate in Patients with Functional Mitral Regurgitation Pooled Analysis of Prospective Studies Presented during Late Breaking Trials Session at CRT...
Press Release Press Release REDUCE FMR Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation and Slows Worsening of Heart Failure Published in peer-reviewed Journal of the American College of Cardiology: Heart Failure Click here...
Press Release Press Release Cardiac Dimensions Reaches 1,000 Implants of Carillon® System, a Minimally Invasive Treatment for Functional Mitral Regurgitation KIRKLAND, WA — July 1, 2019 — Cardiac Dimensions®, a leader in the development of innovative, minimally...
